News

The designation now applies to all approved indications, which includes dermatologic conditions such as psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa.

A real-world retrospective analysis also found that among patients receiving treatment, most were unlikely to use more than 1 treatment or switch to an alternative treatment during the first year of diagnosis.

Discover the top pearls and takeaways from sessions at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina.

Many studies have investigated the associations between lichen sclerosus and vulvar and penile SCCs, as well as genital melanomas.

In this week’s Pointers With Portela, the 208SkinDoc explains why individuals with certain careers have an increased risk of developing skin cancer.

Investigators evaluated the most important markers associated with the pathogenesis of vitiligo, including serum inflammatory and oxidative stress markers.

Vitiligo and psychiatric disorders share a strong connection, with up to 90% of vitiligo patients having comorbid psychiatric conditions.

Non-physician posts accumulated more than 3 times the number of views compared to those created by physicians. Among physicians, dermatologists demonstrated higher average view counts compared to non-dermatologists.

These insights highlight the crucial role of systemic therapies in the comprehensive management of moderate to severe atopic dermatitis.

As cold weather is approaching for much of the country, it is crucial for dermatologists, pediatricians, and families to work together for proper pediatric atopic dermatitis care.

In a cohort of patients in the UK, investigators found that SARS-CoV-2 was associated with increased incidence of several immune-mediated inflammatory diseases, with psoriasis among them.

The addition of an HS dataset adds approximately 26,000 new patient records.

The September 2023 issue of Dermatology Times featured a spotlight on psoriasis research, advances, and treatment options in patients with skin of color. Learn more about the topics covered in each spotlight article.

Brauer’s textbook can be purchased through Amazon and Barnes & Noble.

Check in throughout the month to learn more about the latest treatment pearls and research findings in DermIQ’s spotlight on atopic dermatitis.

Investigators reported successful treatment of psoriasis with risankizumab, despite presence of concomitant HIV infection in 4 male patients.

No concerns were cited about the clinical data package, safety, or label of lebrikizumab.

Prepare your patients with helpful resources each week throughout National Eczema Awareness Month.

New and emerging therapies to treat a variety of skin conditions were presented by George Martin, MD, and Ted Rosen, MD.

Raj Chovatiya, MD, PhD, shares his atopic dermatitis insights.

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Keep up with the latest headlines in dermatology from the past week, including new research into artificial intelligence skin tone bias, dermatologic care of the unhoused patient population, and more.

The hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Trifarotene emerges as an effective and well-tolerated solution for acne across diverse populations.

Learn more about the in-depth topics covered in the September 2023 Frontline Forum BCC management supplement of Dermatology Times.

The distribution of eyebrow and eyelash hair loss in relation to the severity of scalp hair loss remains underexplored, and this study established baseline characteristics.

Late-breaking data, oral presentations, and ePosters from Incyte’s dermatology portfolio will be presented in Berlin, Germany, October 11-14.

Matthew Zirwas, MD, addressed solutions to the toll consistent handwashing, sanitizing, and wearing gloves can take on hands.

Researchers found that continued use of once-daily subantibiotic dose oral doxycycline 40 mg modified-release capsules significantly reduced the relapse rate and inflammatory lesion counts in patients with moderate-to-severe rosacea.